维普中文期刊产品整合服务
11篇 您的检索式:作者名="Marz E"
    题名 作者 年代 出处 被引量
1Acute bronchitis effectiveness of sinupret comparative study with common expectorants in 3187 patients显示文摘Ernst E Marz RW 1997Fortschr Med1997,115,11:1
2The Jak2V617F mutation, PRV-1 overexpression,and EEC formation define a similar cohort of MPD pa- tients 显示文摘Goerttler P Steimle C Marz E 2005Blood2005,106,8:1
3Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10显示文摘Kojro E Gimpl G Lammich S Marz W Fahrenholz F 0,,:1
4The association between parathy-roid hormone and mortality in dialysis patients is modi-fied by wasting显示文摘Drechsler C Krane V Grootendorst D C Ritz E Wink-ler K Marz W 2009Nephrol Dial Transplant2009,24,:1
5The Jak2 V617F mutation,PRV-1 overexpression, and EEC formation define a similar cohort of MPD patients显示文摘Goerttler P S Steimle C Marz E 2005Blood2005,106,8:1
6Acute bronchitis effectiveness of sinupret comparative study with common expectorants in 3187 patients显示文摘Ernst E Marz RW 1997Fortschr Med1997,115,11:1
7The JAK2 V617F mutation,PRV-1 overexpression and EEC formation define a similar cohort of MPD patients显示文摘Goerttler PS Steimle C Marz E 2005Blood2005,106,8:1
8Strict order of (Fuc to Ash-linked Glc- NAc ) fucosyltransferases forming core-difucosylated structures 显示文摘Staudacher E Marz L 1998Glycoconj J1998,,15:1
9Acute bronchitis effectiveness of sinupret comparative study with common expectorants in 3187 patients显示文摘Ernst E Marz RW 1997Fortschr Med1997,,:1
10The Jak2V617F mutation,PRV-1 overexpression,and EEC formation define a similar cohort of MPD patients显示文摘Goerttler PS Steimle C Marz E 2005Blood2005,106,8:1
11Risk factors in cardiovascular patients:Challenges and opportunities to improve secondary prevention显示文摘BACKGROUND Effective management of major cardiovascular risk factors is of great importance to reduce mortality from cardiovascular disease(CVD).The Survey of Risk Factors in Coronary Heart Disease(SURF CHD)II study is a clinical audit of the recording and management of CHD risk factors.It was developed in collaboration with the European Association of Preventive Cardiology and the European Society of Cardiology(ESC).Previous studies have shown that control of major cardiovascular risk factors in patients with established atherosclerotic CVD is generally inadequate.Azerbaijan is a country in the South Caucasus,a region at a very high risk for CVD.AIM To assess adherence to ESC recommendations for secondary prevention of CVD based on the measurement of both modifiable major risk factors and their therapeutic management in patients with confirmed CHD at different hospitals in Baku(Azerbaijan).METHODS Six tertiary health care centers participated in the SURF CHD II study between 2019 and 2021.Information on demographics,risk factors,physical and laboratory data,and medications was collected using a standard questionnaire in consecutive patients aged≥18 years with established CHD during outpatient visits.Data from 687 patients(mean age 59.6±9.58 years;24.9%female)were included in the study.RESULTS Only 15.1%of participants were involved in cardiac rehabilitation programs.The rate of uncontrolled risk factors was high:Systolic blood pressure(BP)(SBP)(54.6%),low-density lipoprotein cholesterol(LDL-C)(86.8%),diabetes mellitus(DM)(60.6%),as well as overweight(66.6%)and obesity(25%).In addition,significant differences in the prevalence and control of some risk factors[smoking,body mass index(BMI),waist circumference,blood glucose(BG),and SBP]between female and male participants were found.The cardiovascular health index score(CHIS)was calculated from the six risk factors:Non-or ex-smoker,BMI<25 kg/m2,moderate/vigorous physical activity,controlled BP(<140/90 mmHg;140/80 mmHg for patients with DM),controlled LDL-C(<70 mg/dL),and controlled BG(glycohemoglobin<7%or BG<126 mg/dL).Good,intermediate,and poor categories of CHIS were identified in 6%,58.3%,and 35.7%of patients,respectively(without statistical differences between female and male patients).CONCLUSION Implementation of the current ESC recommendations for CHD secondary prevention and,in particular,the control rate of BP,are insufficient.Given the fact that patients with different comorbid pathologies are at a very high risk,this is of great importance in the management of such patients.This should be taken into account by healthcare organizers when planning secondary prevention activities and public health protection measures,especially in the regions at a high risk for CVD.A wide range of educational products based on the Clinical Practice Guidelines should be used to improve the adherence of healthcare professionals and patients to the management of CVD risk factors.Rahima Gabulova Anna Marzà-Florensa Uzeyir Rahimov Mahluga Isayeva Shahana Alasgarli Afag Musayeva Sona Gahramanova Firdovsi Ibrahimov Farid Aliyev Galib Imanov Rahmana Rasulova Ilonca Vaartjes Kerstin Klipstein-Grobusch Ian Graham Diederick E Grobbee 2023World Journal of Cardiology2023,15,7:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费